JOURNAL CLUB ARCHIVES
Ventricular Assist Device
|
|
Percutaneous Left Ventricular Support Devices (pdf)
Patients in cardiogenic shock or patients who have left ventricular dysfunction or complex coronary lesions such as multivessel coronary disease, bypass graft disease, or ...
READ MORE >>
|
|
|
First Use of the TandemHeart® Percutaneous Left Ventricular Assist Device (pdf)
Advanced heart failure may be refractory despite aggressive support with inotropic agents and intra-aortic balloon pumping. Implantable left ventricular assist devices are increasingly being used as ...
READ MORE >>
|
|
|
Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock (pdf)
Aims Mortality in cardiogenic shock (CS) following acute myocardial infarction (AMI) remains unacceptably high despite percutaneous coronary intervention (PCI) of the infarcted artery and use of ...
READ MORE >>
|
|
|
A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock (pdf)
Despite major advances in the treatment of heart failure, cardiogenic shock (CGS) remains associated with substantial mortality. Recent data suggest that the TandemHeart percutaneous ventricular assist device ...
READ MORE >>
|
|
|
High-Risk Left Main Coronary Stenting Supported by Percutaneous Left Ventricular Assist Device (pdf)
Percutaneous left ventricular assist devices could nowadays offer a valid support to percutaneous coronary interventions even in very high risk ...
READ MORE >>
|
|
|
Candidate Selection for Long-term Left Ventricular Assist Device Therapy for Refractory Heart Failure (pdf)
The epidemic of heart failure has been widely reported. The reason for its significant increase in incidence are multiple and include improved survival with current drug therapy ...
READ MORE >>
|
|
|
Clinical Outcomes Are Similar in Pulsatile and Nonpulsatile Left Ventricular Assist Device Recipients (pdf)
Despite concerns about the adequacy of support provided by continuous-flow left ventricular assist devices (LVADs), direct comparisons of patient characteristics ...
READ MORE >>
|
|
|
Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure (pdf)
In patients with severe heart failure, prolonged unloading of the myocardium with the use of a left ventricular assist device has been reported to lead to myocardial ...
READ MORE >>
|
|
|
First Clinical Experience With the Incor Left Ventricular Assist Device (pdf)
The Incor (Berlin Heart AG, Germany) is a small (200 g), implantable, magnetically accentuated axial flow pump (non-pulsatile flow) designed to support the left ventricle for extended ...
READ MORE >>
|
|
|
Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study (pdf)
Left ventricular assist device (LVAD) insertion after anterior wall myocardial infarction complicated by cardiogenic shock is an accepted ...
READ MORE >>
|
|
|
LONG-TERM USE OF A LEFT VENTRICULAR ASSIST DEVICE FOR END-STAGE HEART FAILURE (pdf)
Implantable left ventricular assist devices have benefited patients with end-stage heart failure as a bridge to cardiac transplantation ...
READ MORE >>
|
|
|
First Clinical Use of the Redesigned HeartMate® II Left Ventricular Assist System in the United States (pdf)
Axial flow ventricular assist devices show great promise as a potential treatment for patients with end-stage ...
READ MORE >>
|
|
|
Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation (pdf)
Despite advances in heart transplantation and mechanical circulatory support, mortality among transplant candidates ...
READ MORE >>
|
|
|
Long-Term Destination Therapy with the Heart Mate XVE Left Ventricular Assist Device: Improved Outcomes since the REMATCH Study (pdf)
Heart failure (HF) remains a major public health problem of epidemic proportion. It is estimated that 5 million individuals ...
READ MORE >>
|
|
|
The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program (pdf)
Options for the circulatory support of pediatric patients under the age of 5 years are currently limited to short-term extracorporeal devices, the use of ...
READ MORE >>
|
|
|
Outcomes of Children Bridged to Heart Transplantation With Ventricular Assist Devices: A Multi-Institutional Study (pdf)
Current ventricular assist devices (VADs) in the United States are designed primarily for adult use. Data on VADs as a bridge to transplantation in children ...
READ MORE >>
|
